Contribution of patient registries to regulatory decision making on rare diseases medicinal products in Europe by Carla J. Jonker, Carla J. Jonker, Elisabeth Bakker, Elisabeth Bakker, Xavier Kurz, Kelly Plueschke

Connect to this object online.

Precision medicine in regulatory decision making: Biomarkers used for patient selection in European Public Assessment Reports from 2018 to 2020 by Elisabeth Bakker, Viktoriia Starokozhko, Jet W. M. Kraaijvanger, Hiddo J. L. Heerspink, Peter G. M. Mol

Connect to this object online.

Use cases of registry‐based randomized controlled trials-A review of the registries' contributions and constraints by Nadine Kubesch, Sneha Gaitonde, Uarda Petriti, Elisabeth Bakker, Swati Basu, Laura Ellen Birks, Elodie Aubrun, Sieta T. de Vries, Rahel Schneider

Connect to this object online.

Perspectives on a Way Forward to Implementation of Precision Medicine in Patients With Diabetic Kidney Disease; Results of a Stakeholder Consensus-Building Meeting by Elisabeth Bakker, Peter G. M. Mol, Peter G. M. Mol, Peter G. M. Mol, João Nabais, João Nabais, Thorsten Vetter, Matthias Kretzler, John J. Nolan, Gert Mayer, Anna K. Sundgren, Hiddo J. L. Heerspink, Anja Schiel, Anja Schiel, Sieta T. de Vries, Maria F. Gomez, Friedrich Schulze, Dick de Zeeuw, Michelle J. Pena, for the BEAt-DKD Consortium

Connect to this object online.